Is it different from JNJ/Realize? I know AGN dominants this market, just trying to understand the competition. I had the impression banding is losing popularity to gastric bypass and sleeve gastrectomy. Also arn't all these procedures aiming at the severe obesity (BMI >40) cases while drugs like lorcaserin will be more adequate in mild to moderate cases?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.